A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
for Macular Degeneration
48 locations incl. Gilbert
Sponsor: EyeBiotech Ltd.
Sex: All·Age: 50+
Code: NCT07496567·Phase 2, Phase 3·Recruiting·Listed Mar 2026
Retina Associates, LLC
Clinical research site in Lenexa, Kansas · 8600 QUIVIRA RD STE 100, LENEXA, KS 66215-2857 · (913) 831-7400
Part of Retina Associates
As of July 2026, 2 paid clinical trials are recruiting at Retina Associates, LLC in Lenexa, Kansas. Active studies at this site cover conditions such as Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD) and Choroidal Neovascularization. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Retina Associates, LLC (2)
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
for Age-related Macular Degeneration (AMD)
140 locations incl. Chandler
Sponsor: Regeneron Pharmaceuticals
Sex: All·Age: 50 - 85
Code: NCT06541704·Phase 3·Recruiting·Listed Aug 2024
More research sites in Lenexa
- GSK Investigational Site (3 trials)
- ICON - Lenexa (2 trials)
- Johnson County Clin-Trials (2 trials)
- Johnson County Clinical Trials (2 trials)
- Lenexa Clinic (2 trials)
- Grifols Investigative Site (1 trial)
- ICON (1 trial)
- ICON Clinical Research (1 trial)
- ICON Clinical Research: Lenexa (1 trial)
- ICON Early Phase Services, LLC (1 trial)